Overview
The government has committed up to £520 million for life sciences manufacturing, to help deliver on the government’s missions to kickstart economic growth and build an NHS fit for the future.
The LSIMF will be UK and sector wide and will provide capital grants for investments in the manufacture of:
- Human medicines (this includes both the manufacture of active pharmaceutical ingredients (API) / drug substance and finished product / drug product).
- Medical diagnostics – for both disease identification and monitoring.
- MedTech products – all types of medical devices related to human health.
The fund will remain open until all the funding has been allocated.
Who Can Apply
Applicants will be prioritised based on their alignment to the fund’s objectives:
- To increase UK health resilience by strengthening the UK’s manufacturing capacity and capability. We define health resilience as the UK’s ability to withstand and recover from health emergencies such as pandemics, long-term healthcare challenges and system shocks such as supply chain disruption.
- To create economic opportunity through investments that will make a substantial contribution to Gross Value Added (GVA) and provide high-wage, high-skilled jobs around the UK.
Eligibility
Your company
To be eligible for the fund, your company must be a:
- UK registered company.
- Wholly private sector business.
- Product developer, contract development manufacturing organisation, or a generics manufacturer.
Your project
To be eligible for the fund, your project must:
- Have a total cost (capital and non-capital costs) of at least £8 million
- Be located in the UK
- Be primarily a capital investment
- Be a single company investment (as opposed to forming a partnership between companies or other types of organisations)
- Require only the amount of grant requested to proceed. For example, without the specific amount of funding you are requesting your project wouldn’t go ahead or go ahead at a smaller scale, go ahead overseas or would be significantly delayed (3 years or more)
- Be a manufacturing project for the manufacture of:
- Human medicines (this includes both the manufacture of active pharmaceutical ingredients (API) / drug substance and finished product / drug product).
- Medical diagnostics – for both disease identification and monitoring
- MedTech products – all types of medical devices related to human health.
The fund is open to applications for both MHRA-licenced products and products in development where a MHRA licence is intended to be sought for commercial scale-up, for example a manufacturing project for clinical trials.
- Manufacturing facilities are required to work to Good Manufacturing Practice (GMP) and the facility be intended to support clinical and/or commercial manufacture of API or drug product.
- Manufacturers of medicinal diagnostics and medical devices must confirm that their device meets or intends to meet the requirements of the Medical Devices Regulations 2002.
Exclusions
Projects relating to the following are not eligible for funding from LSIMF
- Veterinary medicine
- Herbal medicines
- Nutritional supplements or vitamins
- Raw ingredients (e.g solvents, buffers and cleaning agents)
- The production of single-use consumables that are not integrated into a larger product (e.g manufacturing syringes independently from diagnostic kits)
- Secondary packaging for products or materials (e.g package inserts, labelling and boxes).
How to apply
The LSIMF application process has 3 sections.
Section 1: Expression of Interest (EOI)
We will use the EOI to evaluate your basic eligibility and identify projects that align with LSIMF’s objectives. Eligible projects will be invited to the next stage.
Section 2: Health resilience assessment
We will assess the health resilience benefits of your project:
- You will need to describe the health resilience benefits of your project. This stage is assessed by a panel of cross-government officials.
(b) Panel interview
- You will be required to give a brief presentation on the health resilience benefits of your project, followed by a question and answer session.
- The interview will be hosted by a panel of independent manufacturing experts who will further assess your project’s health resilience benefits.
Section 3: Financial and economic assessment
- If you are successful following the health resilience assessment, you will be invited to complete application form 2. Questions will cover eligibility, company and project specifics and financial information, markets and economic impacts and project risks.
- You will be required to provide further documentation to evidence your company’s financial position, eligibility and project viability.
(b) Due diligence
We will assess whether your grant request offers good value for money, ensure compatibility with subsidy control regulations, validate what would happen without a grant, and confirm the project’s deliverability, employment outputs and your ability to finance it.
You may be required to provide further documentation to evidence your company’s financial position, eligibility and project deliverability.
Submit an Expression of Interest
Your EOI will be used to assess your project’s eligibility and can be submitted at any time whilst the fund is open. If your project is deemed eligible, you will be invited to submit an application.
Call 
Back
